{"id":363,"date":"2013-06-18T10:31:04","date_gmt":"2013-06-18T09:31:04","guid":{"rendered":"http:\/\/psnc.jellyha.us\/?page_id=363"},"modified":"2024-07-12T11:03:24","modified_gmt":"2024-07-12T10:03:24","slug":"endorsement-guidance","status":"publish","type":"page","link":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/","title":{"rendered":"Endorsement guidance"},"content":{"rendered":"<p style=\"text-align: justify;\">This is a quick reference guide to the prescription endorsements which pharmacy teams may need to use. Accurate endorsement is vital to ensuring correct payment from the NHS Business Services Authority (NHSBSA).<\/p>\n<p style=\"text-align: justify;\">Pharmacy teams are able to download the <a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2020\/11\/Prescription-endorsements-factsheet.pdf\"><strong>Dispensing Factsheet: Prescription endorsements<\/strong><\/a> for more\u00a0information.<\/p>\n<p style=\"text-align: justify;\">Watch our video where we our Drug Tariff experts guide you through the endorsement process, outlining endorsing and submission good practice <strong><a href=\"https:\/\/cpe.org.uk\/psncs-work\/our-events\/register-your-interest-in-our-webinar\/endorsing-and-submission-good-practice-workshop\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a><\/strong>.<\/p>\n<hr \/>\n<h2 style=\"text-align: justify;\"><strong>General endorsements<\/strong><\/h2>\n<p style=\"text-align: justify;\">The guidance below is intended as a quick reference only.<\/p>\n<table style=\"height: 114px; width: 97.9096%;\" width=\"798\">\n<tbody>\n<tr style=\"background-color: #659200; height: 24px;\">\n<td style=\"text-align: center; height: 24px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>Prescribed item<\/strong><\/span><\/td>\n<td style=\"text-align: center; height: 24px; width: 116.956%;\" width=\"444\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>Required endorsement<\/strong><\/span><\/td>\n<\/tr>\n<tr style=\"height: 80.8125px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A generic medicine listed in Part VIIIA of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size\u00a0\u2014 where\u00a0 multiple pack sizes are listed.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 80px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A generic medicine listed in Part VIIIB of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">\u00a0<strong>SP<\/strong> or <strong>ED<\/strong>\u2014 where appropriate.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 200px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A generic medicine which is not listed in Part VIIIA of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Brand name or manufacturer\/supplier; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size\u00a0\u2014 where there are multiple pack sizes available.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">If the product does not have a price listed on the Dictionary of Medicines and Devices (dm+d)*, also endorse:<\/span><\/p>\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Net price before discount and exc. VAT<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 304px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">An unlicensed medicine (or special) or import which is not listed in Part VIIIB of the Drug Tariff and has been sourced under a manufacturer\u2019s specials\/importer\u2019s licence** issued by the MHRA.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Amount dispensed over pack size used;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Invoice price per pack size from which the order was supplied less any discount or rebate;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Manufacturers\u2019\/importers\u2019 MHRA license number;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Batch number of the product supplied;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>SP<\/strong>\u00a0\u2014 for costs incurred in obtaining the item<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">(more information at <a href=\"https:\/\/cpe.org.uk\/specials\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/specials<\/a>)\u00a0<a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/04\/PSNC-Briefing-017.15-Dispensing-Factsheet-Unlicensed-Specials-and-Imports.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dispensing Factsheet &#8211; Unlicensed specials and imports<\/a><\/span><\/td>\n<\/tr>\n<tr style=\"height: 200px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">An unlicensed medicine (or special) which is not listed in Part VIIIB and has been manufactured under the Section 10 exemption from the Medicines Act 1968 (either by the contractor or a third party).<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Names;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Quantities;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Cost of the ingredients used in preparing the product; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>ED<\/strong> \u2014 for costs incurred in dispensing a product prepared under the Section 10 exemption.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">(more information at <a href=\"https:\/\/cpe.org.uk\/specials\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/specials<\/a>).<a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/04\/PSNC-Briefing-017.15-Dispensing-Factsheet-Unlicensed-Specials-and-Imports.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dispensing Factsheet &#8211; Unlicensed specials and imports<\/a><\/span><\/td>\n<\/tr>\n<tr style=\"height: 160px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A branded medicine.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">If the product does not have a price listed in the dm+d, also endorse:<\/span><\/p>\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Net price \u2014 before discount and exc. VAT<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 232px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A generic appliance which is only listed generically in Part IX of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size\u00a0\u2014 where multiple pack sizes are available.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">For elastic hosiery, prescriptions should indicate:<\/span><\/p>\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Total quantity to be supplied;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Description of the article\u00a0(e.g. circular knit, below knee); and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Compression class.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 344px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A generic appliance which is listed by brand or manufacturer in Part IX of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Brand or manufacturer\u2019s name as listed in the Tariff; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size \u2014 only where there are multiple pack sizes listed in the Tariff.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Note: some appliances have default prices listed at the beginning of the relevant Drug Tariff section, which are used for pricing in this situation. These are: catheters, elasticated tubular bandages, absorbent perforated plastic film faced dressings, permeable non-woven synthetic adhesive tape BP 1988, and peak flow meters. To be reimbursed for any of the above products which may be priced higher than the default price, the prescription must be returned to the prescriber for amendment to include a specific brand name as listed in the Drug Tariff.<\/span><\/td>\n<\/tr>\n<tr style=\"height: 80px;\">\n<td style=\"height: 10px; width: 40.9167%;\" width=\"331\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">A branded appliance which is listed by brand or manufacturer in Part IX of the Drug Tariff.<\/span><\/td>\n<td style=\"height: 10px; width: 116.956%;\" width=\"444\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pack size \u2014 where there are multiple pack sizes listed.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\"><em>*The Dictionary of Medicines and Devices is the database used by the NHS to standardise the language used to describe medicines within the NHS. This database also contains information regarding the price of medicines. Pharmacy staff can access this database by visiting <a href=\"https:\/\/dmd-browser.nhsbsa.nhs.uk\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"broken_link\">https:\/\/dmd-browser.nhsbsa.nhs.uk\/<\/a>.\u00a0<\/em><\/p>\n<p style=\"text-align: justify;\"><em>**The manufacturer\u2019s specials\/importer\u2019s license number can be found on the invoice or CoC\/CoA for the product.<\/em><\/p>\n<p style=\"text-align: justify;\"><div class=\"trigger the-trigger\"><strong>Specific dispenser endorsements<\/strong><div class=\"icon\"><\/div><\/div><div class=\"toggle_container\"><\/p>\n<p style=\"text-align: justify;\">Below are the most commonly used endorsements, but pharmacy staff will need to check for an item\u2019s eligibility.<\/p>\n<table style=\"width: 98.0469%; height: 154px;\" width=\"696\">\n<tbody>\n<tr style=\"background-color: #659200;\">\n<td style=\"text-align: center; width: 32.8012%; height: 24px;\" width=\"208\"><span style=\"color: #ffffff; font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>Category<\/strong><\/span><\/td>\n<td style=\"text-align: center; width: 143.612%; height: 24px;\" width=\"488\"><span style=\"color: #ffffff; font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>Required endorsement<\/strong><\/span><\/td>\n<\/tr>\n<tr style=\"height: 43px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Broken Bulk<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>BB;<\/strong>\u00a0and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">amount dispensed over pack size used\u00a0(more information at <a href=\"https:\/\/cpe.org.uk\/bb\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/bb<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 12px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Extemporaneously Dispensed<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>ED<\/strong>\u00a0(more information at <a href=\"https:\/\/cpe.org.uk\/specials\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/specials<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 98px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Hosiery<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Compression class;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Article style;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Quantity;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Knit; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Made to measure \u2014 if appropriate.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 13px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Instalment Dispensing<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Date;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Quantity; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Pharmacist initials for each instalment (more information at <a href=\"https:\/\/cpe.org.uk\/mda\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/mda<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Measured and Fitted<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>MF<\/strong><\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Not Dispensed<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>ND<\/strong> and <strong>score through<\/strong> the item in the prescribing area.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 31px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Out of Pocket Expenses<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>OOP<\/strong> on paper prescriptions or <strong>XP<\/strong>\u00a0on EPSR2 prescription;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Name or description of the charge; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Price paid (more information at <a href=\"https:\/\/cpe.org.uk\/oop\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/oop<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 36px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Packaged Doses (for oral liquid methadone)<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>PD;<\/strong> and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">The number of additional doses packaged separately (more information at <a href=\"https:\/\/cpe.org.uk\/methadone\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/methadone<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 13px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Prescriber Contacted<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>PC;<\/strong><\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">The missing information; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Date and initials.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Prescriber Not Contacted<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>PNC;<\/strong><\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">The missing information; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Date and initials.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 32.8012%;\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Serious Shortage Protocols (SSPs)<br \/>\n<\/span><\/td>\n<td style=\"width: 143.612%;\">\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">There are two types of SSPs that may be granted:<\/span><\/p>\n<p><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">\u2022 <strong>Single Dispensed Product SSP<\/strong> \u2013 where a prescribed item is replaced by one replacement item<br \/>\n\u2022 <strong>Multiple Dispensed Product SSP<\/strong> \u2013 where a prescribed item is replaced by two or more items.<\/span><\/p>\n<p>See our <a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2021\/11\/PSNC-Briefing-011.21-Serious-Shortage-Protocols-SSPs-updated-endorsing-guidance-Feb-2022.pdf\">SSP endorsing guidance<\/a> for details of how to correctly endorse a prescription for an SSP.<\/td>\n<\/tr>\n<tr style=\"height: 23px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Trusses<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Single or double;<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Position; and<\/span><\/li>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Type.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 32.8012%; height: 10px;\" width=\"208\"><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\">Unlicensed Specials and Imports<\/span><\/td>\n<td style=\"width: 143.612%; height: 10px;\" width=\"488\">\n<ul>\n<li><span style=\"font-size: 12pt; font-family: georgia, palatino, serif;\"><strong>SP<\/strong>\u00a0(more information at <a href=\"https:\/\/cpe.org.uk\/specials\" target=\"_blank\" rel=\"noopener noreferrer\">cpe.org.uk\/specials<\/a>).<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\"><\/div><div class=\"trigger the-trigger\"><strong>Prescriber endorsements<\/strong><div class=\"icon\"><\/div><\/div><div class=\"toggle_container\"><\/p>\n<p style=\"text-align: justify;\">Below is a list of the endorsements which only a prescriber can add to a prescription item.<\/p>\n<table style=\"width: 98.1306%; height: 74px;\" width=\"690\">\n<tbody>\n<tr style=\"background-color: #659200;\">\n<td style=\"text-align: center; width: 16.836%; height: 24px;\" width=\"104\"><strong><span style=\"color: #ffffff;\">Endorsement<\/span><\/strong><\/td>\n<td style=\"text-align: center; width: 164.335%; height: 24px;\" width=\"586\"><strong><span style=\"color: #ffffff;\">What it means for dispensing<\/span><\/strong><\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 16.836%; height: 10px;\" width=\"104\"><strong>ACBS<\/strong><\/td>\n<td style=\"width: 164.335%; height: 10px;\" width=\"586\">No impact on dispensing.\u00a0If an item which is found on the Borderline Substances list (Part XV of DT) has not been endorsed by the prescriber, this product can still be dispensed as it isn\u2019t a compulsory requirement (but the prescriber may be questioned by the Regional Team later).<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 16.836%; height: 10px;\" width=\"104\"><strong>SLS*<\/strong><\/td>\n<td style=\"width: 164.335%; height: 10px;\" width=\"586\">If required, this endorsement must have been made by the prescriber before dispensing.\u00a0If a medicine which is found in the Selected List Scheme (Part XVIIIB of DT) has not been endorsed by the prescriber, the prescription would need to be returned to the prescriber for amendment \u2014 pharmacy staff cannot make this endorsement themselves.<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 16.836%; height: 10px;\"><strong>FS<\/strong><\/td>\n<td style=\"width: 164.335%; height: 10px;\">FS enables prescribers to endorse prescriptions for STIs to indicate to dispensers that the patient should not be charged. The FS endorsement should not\u00a0be manually added to the EPS dosage instructions field as this would not allow a pharmacy to supply any treatment for STIs free-of-charge against NHS prescriptions.<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 16.836%; height: 10px;\" width=\"104\">Either &#8216;<strong>OC<\/strong>&#8216;, &#8216;<strong>CC<\/strong>&#8216;\u00a0or &#8216;\u2640&#8217;<\/td>\n<td style=\"width: 164.335%; height: 10px;\" width=\"586\">This endorsement is the prescriber declaring that it is to be used for contraceptive purposes.\u00a0No patient charge is payable for this item.<\/td>\n<\/tr>\n<tr style=\"height: 10px;\">\n<td style=\"width: 16.836%; height: 10px;\" width=\"104\">Bulk Prescription<\/td>\n<td style=\"width: 164.335%; height: 10px;\" width=\"586\">This endorsement is the prescriber declaring that the criteria for issuing bulk prescriptions have been met. No patient charge is payable for this item.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\">*Pharmacy teams should note that <a href=\"https:\/\/cpe.org.uk\/our-news\/regulations-restricting-the-sale-and-supply-of-gonadotrophin-releasing-hormone-analogues\/\">regulations have been introduced<\/a> to restrict the prescribing and supply of puberty suppressing hormones \/ gonadotrophin releasing hormone (GnRH) analogues to children and young people under 18 for the purposes of gender dysphoria \/ gender incongruence. <strong>From 26 June 2024 onwards, all GnRH NHS prescriptions are required to have the SLS endorsement.<\/strong><\/p>\n<p style=\"text-align: justify;\">The new arrangements apply to medicines that consist of or contain buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin, or triptorelin. This includes, but is not limited to, medicines sold under the brand names: Decapeptyl\u00ae, Gonapeptyl Depot\u00ae, Salvacyl\u00ae, Prostap\u00ae, Staladex\u00ae, Zoladex\u00ae, Synarel\u00ae. Refer to our\u00a0<a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2024\/07\/Briefing-011.24-New-restrictions-on-the-prescriptions-and-supply-of-puberty-blockers-1.pdf\">Briefing: 011\/24: New restrictions on the prescriptions and supply of puberty blockers<\/a>\u00a0for a full list of medicines covered by the arrangements and FAQs.<strong><br \/>\n<\/strong><\/p>\n<p style=\"text-align: justify;\">For more information see our page\u00a0<a href=\"https:\/\/cpe.org.uk\/quality-and-regulations\/other-regulatory-and-terms-of-service-requirments\/gonadotrophin-releasing-hormone-gnrh-prescription-regulations\/\">Gonadotrophin Releasing Hormone (GnRH) Prescription Regulations<\/a>.<\/p>\n<p style=\"text-align: justify;\">Items included in the &#8216;Selected List Scheme&#8217; which can be found in <a href=\"https:\/\/www.nhsbsa.nhs.uk\/pharmacies-gp-practices-and-appliance-contractors\/drug-tariff\">Part XVIIIB (drugs, medicines and other substances that may be ordered only in certain circumstances)<\/a> of the Drug Tariff can only be prescribed for the patient groups and for the purpose(s) listed in the Tariff.<\/p>\n<p style=\"text-align: justify;\">Prescribers must endorse these products with SLS.\u202f<span style=\"text-decoration: underline;\">If the SLS endorsement is missing, the prescription should be returned to the prescriber for amendment to include the SLS endorsement. <\/span><strong>Pharmacy staff cannot make the SLS endorsement themselves.<\/strong><\/p>\n<p style=\"text-align: justify;\"><\/div><div class=\"trigger the-trigger\"><strong>Electronic Prescription Service Endorsement Guidance<\/strong><div class=\"icon\"><\/div><\/div><div class=\"toggle_container\"><\/p>\n<p style=\"text-align: justify;\">This endorsement document is a guide to the endorsement codes used for electronic prescription dispensing. \u00a0The guidance has been jointly produced by Community Pharmacy England, the Department of Health and Social Care and the NHSBSA.<\/p>\n<ul style=\"text-align: justify;\">\n<li><a href=\"https:\/\/www.nhsbsa.nhs.uk\/PrescriptionServices\/1972.aspx\">Electronic Prescription Service Endorsement Guidance<\/a><\/li>\n<li><a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/Prescription_Amendments.pdf\">Quick Reference to Permissible Prescription Form Amendments<\/a><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><\/div><div class=\"trigger the-trigger\"><strong>Methadone and Instalment Dispensing<\/strong><div class=\"icon\"><\/div><\/div><div class=\"toggle_container\"><\/p>\n<p style=\"text-align: justify;\">Further information on endorsements for Controlled Drug prescriptions can be found on the \u2018<a class=\"fui-Link ___1rxvrpe f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1hu3pq6 f11qmguv f19f4twv f1tyq0we f1g0x7ka fhxju0i f1qch9an f1cnd47f fqv5qza f1vmzxwi f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn\" title=\"https:\/\/cpe.org.uk\/dispensing-supply\/dispensing-controlled-drugs\/\" href=\"https:\/\/cpe.org.uk\/dispensing-supply\/dispensing-controlled-drugs\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"Link Dispensing Controlled Drugs\"><i><strong>Dispensing Controlled Drugs<\/strong><\/i><\/a>\u2018 page.<\/p>\n<p style=\"text-align: justify;\"><\/div><\/p>\n<hr \/>\n<h2 style=\"text-align: justify;\"><strong>Related Resources<\/strong><\/h2>\n<p><a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2021\/11\/PSNC-Briefing-011.21-Serious-Shortage-Protocols-SSPs-updated-endorsing-guidance-Feb-2022.pdf\">Community Pharmacy England Briefing 011\/21: Serious Shortage Protocols (SSPs) updated endorsing guidance<\/a><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/cpe.org.uk\/psncs-work\/our-events\/register-your-interest-in-our-webinar\/endorsing-and-submission-good-practice-workshop\/\" target=\"_blank\" rel=\"noopener noreferrer\">Community Pharmacy England webinar on endorsing and submission good practice.<\/a><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/06\/CPN-Factsheet-Prescription-Factsheet-May-15.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Dispensing Factsheet: Prescription Endorsement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"excerpt","protected":false},"author":12,"featured_media":1779,"parent":600,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_lmt_disableupdate":"no","_lmt_disable":"","episode_type":"","audio_file":"","cover_image":"","cover_image_id":"","duration":"","filesize":"","date_recorded":"","explicit":"","block":"","filesize_raw":"","footnotes":""},"tags":[],"class_list":["post-363","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Endorsement guidance - Community Pharmacy England<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endorsement guidance - Community Pharmacy England\" \/>\n<meta property=\"og:description\" content=\"This is a quick reference guide to the prescription endorsements which pharmacy teams may need to use. Accurate endorsement is vital to ensuring correct payment from the NHS Business Services Authority (NHSBSA). Pharmacy teams are able to download the Dispensing Factsheet: Prescription endorsements for more\u00a0information. Watch our video where we our Drug Tariff experts guide [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/\" \/>\n<meta property=\"og:site_name\" content=\"Community Pharmacy England\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-12T10:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/\",\"url\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/\",\"name\":\"Endorsement guidance - Community Pharmacy England\",\"isPartOf\":{\"@id\":\"https:\/\/cpe.org.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg\",\"datePublished\":\"2013-06-18T09:31:04+00:00\",\"dateModified\":\"2024-07-12T10:03:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage\",\"url\":\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg\",\"contentUrl\":\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cpe.org.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Funding &#038; Reimbursement\",\"item\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Reimbursement\",\"item\":\"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Endorsement guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cpe.org.uk\/#website\",\"url\":\"https:\/\/cpe.org.uk\/\",\"name\":\"Community Pharmacy England\",\"description\":\"The representative body for all community pharmacy owners in England\",\"publisher\":{\"@id\":\"https:\/\/cpe.org.uk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cpe.org.uk\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cpe.org.uk\/#organization\",\"name\":\"Community Pharmacy England\",\"url\":\"https:\/\/cpe.org.uk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cpe.org.uk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2023\/05\/CPE-Logo.svg\",\"contentUrl\":\"https:\/\/cpe.org.uk\/wp-content\/uploads\/2023\/05\/CPE-Logo.svg\",\"width\":206,\"height\":85,\"caption\":\"Community Pharmacy England\"},\"image\":{\"@id\":\"https:\/\/cpe.org.uk\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endorsement guidance - Community Pharmacy England","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/","og_locale":"en_GB","og_type":"article","og_title":"Endorsement guidance - Community Pharmacy England","og_description":"This is a quick reference guide to the prescription endorsements which pharmacy teams may need to use. Accurate endorsement is vital to ensuring correct payment from the NHS Business Services Authority (NHSBSA). Pharmacy teams are able to download the Dispensing Factsheet: Prescription endorsements for more\u00a0information. Watch our video where we our Drug Tariff experts guide [...]","og_url":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/","og_site_name":"Community Pharmacy England","article_modified_time":"2024-07-12T10:03:24+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/","url":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/","name":"Endorsement guidance - Community Pharmacy England","isPartOf":{"@id":"https:\/\/cpe.org.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage"},"image":{"@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg","datePublished":"2013-06-18T09:31:04+00:00","dateModified":"2024-07-12T10:03:24+00:00","breadcrumb":{"@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#primaryimage","url":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg","contentUrl":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2013\/07\/MG_5496-2-53.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/endorsement-guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cpe.org.uk\/"},{"@type":"ListItem","position":2,"name":"Funding &#038; Reimbursement","item":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/"},{"@type":"ListItem","position":3,"name":"Reimbursement","item":"https:\/\/cpe.org.uk\/funding-and-reimbursement\/reimbursement\/"},{"@type":"ListItem","position":4,"name":"Endorsement guidance"}]},{"@type":"WebSite","@id":"https:\/\/cpe.org.uk\/#website","url":"https:\/\/cpe.org.uk\/","name":"Community Pharmacy England","description":"The representative body for all community pharmacy owners in England","publisher":{"@id":"https:\/\/cpe.org.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cpe.org.uk\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/cpe.org.uk\/#organization","name":"Community Pharmacy England","url":"https:\/\/cpe.org.uk\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cpe.org.uk\/#\/schema\/logo\/image\/","url":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2023\/05\/CPE-Logo.svg","contentUrl":"https:\/\/cpe.org.uk\/wp-content\/uploads\/2023\/05\/CPE-Logo.svg","width":206,"height":85,"caption":"Community Pharmacy England"},"image":{"@id":"https:\/\/cpe.org.uk\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/pages\/363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/comments?post=363"}],"version-history":[{"count":0,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/pages\/363\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/pages\/600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/media\/1779"}],"wp:attachment":[{"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/media?parent=363"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cpe.org.uk\/wp-json\/wp\/v2\/tags?post=363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}